|
業務類別
|
-- |
|
業務概覽
|
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. Its product, KidneyIntelX, is designed to improve kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company's service, KidneyIntelX.dkd, enables the assessment of risk for early-stage chronic kidney disease progression. KidneyIntelX uses a proprietary algorithm combining blood-based biomarkers, inherited genetics, and electronic health record data to generate a patient risk score predicting rapid kidney function decline. |
| 公司地址
| 2 Leman Street, London, GBR, E1W 9US |
| 電話號碼
| +44 2079338790 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.renalytix.com |
| 員工數量
| 46 |
| Mr. Salim Hamir |
Company Secretary |
-- |
30/12/2025 |
| Mr. James Renwick McCullough |
Executive Director,Chief Executive Officer |
美元 427.00K |
09/12/2025 |
| Mr. Fergus Fleming |
Executive Director,Chief Technical Officer |
美元 311.00K |
09/12/2025 |
|
|
| Mr. Christopher Harwood Bernard Mills |
Non-Executive Director |
09/12/2025 |
| Mr. Julian Huw Baines MBE |
Non-Executive Director,Chairman |
30/12/2025 |
| Mr. James Renwick McCullough |
Executive Director,Chief Executive Officer |
09/12/2025 |
| Mr. Fergus Fleming |
Executive Director,Chief Technical Officer |
09/12/2025 |
| Dr. Erik Lium |
Non-Executive Director |
09/12/2025 |
| Ms. Catherine Havlik Coste |
Non-Executive Director |
30/12/2025 |
| Mr. Robert Graham Naylor |
Non-Executive Director |
09/12/2025 |
|
|
|
|
